Ontario Institute for Regenerative Medicine

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	NCT ID
A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis	CNS demyelinating autoimmune disease, autoimmune disease, autoimmune disorder of the nervous system, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder	Recruiting	Phase 1 / Phase 2	2025-09-23	NCT04121468
Cellular Therapy for Extreme Preterm Infants at Risk of Developing Bronchopulmonary Dysplasia	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases and Pregnancy Complications, Infant, Newborn, Diseases, Infant, Premature, Diseases, Lung Injury, Obstetric Labor Complications, Obstetric Labor, Premature, Premature Birth, Urogenital Diseases, Ventilator-Induced Lung Injury, bronchopulmonary dysplasia, lung disorder, pregnancy disorder, respiratory system disorder	Active, not recruiting	Phase 1	2025-07-16	NCT04255147
A Phase I, Single-blind, Randomized Study of the Safety and Efficacy of Cellularized Integra® Using Autologous Burn-derived Stem Cells	Fibrosis, Pathologic Processes, Pathological Conditions, Signs and Symptoms, burn, injury, severe cutaneous adverse reaction	Not yet recruiting	Phase 1	2023-12-15	NCT05344521

Clinical trials